Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Lancet HIV. 2019 Sep;6(9):e601–e612. doi: 10.1016/S2352-3018(19)30155-9

Figure 3: Plasma concentrations of (A) efavirenz, (B) atazanavir, and (C) ritonavir.

Figure 3:

Line represents median (interquartile range) value in ng/mL per timepoint. Day 0 represents antiretroviral therapy alone, Day 21 represents antiretroviral therapy in combination with the contraceptive vaginal ring.